BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma

BACKGROUND: Nonfunctioning pituitary adenoma (NFPA) and growth hormone pituitary adenoma (GHPA) are major subtypes of pituitary adenomas (PAs). The primary treatment is surgical resection. However, radical excision remains challenging, and few effective medical therapies are available. It is urgent...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Shi, Chengzhang, Ye, Zhao, Han, Jie, Ye, Xiaoqing, Lu, Wenchao, Ji, Chenxing, Li, Zizhou, Ma, Zengyi, Zhang, Qilin, Zhang, Yichao, He, Wenqiang, Chen, Zhengyuan, Cao, Xiaoyun, Shou, Xuefei, Zhou, Xiang, Wang, Yongfei, Zhang, Zhaoyun, Li, Yiming, Ye, Hongying, He, Min, Chen, Hong, Cheng, Haixia, Sun, Jun, Cai, Jianyong, Huang, Chuanxin, Ye, Fei, Luo, Cheng, Zhou, Bing, Ding, Hong, Zhao, Yao
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Basic and Translational Investigations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594556/
https://ncbi.nlm.nih.gov/pubmed/32246150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa084
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料